Shepherd Financial Partners LLC Buys Shares of 8,370 Danaher Corporation $DHR

Key Points

• Shepherd Financial Partners bought 8,370 Danaher shares worth approximately $1.59 million during the second quarter. Several other institutional investors also initiated positions, with institutions collectively owning 79.05% of the stock.
• Danaher exceeded quarterly expectations, reporting $1.94 in EPS versus the $1.85 consensus and $6.26 billion in revenue, up 5.5% year over year.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $228.91, while Danaher shares recently traded at $211.92.

Shepherd Financial Partners LLC purchased a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 8,370 shares of the conglomerate's stock, valued at approximately $1,594,000.

Other hedge funds have also recently made changes to their positions in the company. Johnson Financial Group Inc. bought a new stake in Danaher during the second quarter valued at about $333,000. Tocqueville Asset Management L.P. purchased a new position in Danaher in the second quarter valued at about $11,299,000. one8zero8 LLC bought a new position in Danaher in the second quarter worth about $3,257,000. Kentucky Farm Bureau Mutual Insurance Co purchased a new stake in shares of Danaher during the second quarter valued at about $1,905,000. Finally, Addison Advisors LLC purchased a new stake in shares of Danaher during the second quarter valued at about $143,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of DHR opened at $211.92 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company's fifty day moving average price is $194.30 and its 200-day moving average price is $192.44. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a market capitalization of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $0.77 EPS. On average, equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price objective on the stock. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. Wall Street Zen downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Wolfe Research downgraded Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Finally, HSBC decreased their price objective on Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source